By 2025, the sector could explode to a value of $727.1 billion at a CAGR of 7.4%, according to Grand View Research thanks to sizable near-term catalysts.
This sector could be one of the safest, most recession-proof investments around, because we can’t stop folks from aging, and needing treatments for a large range of medical issues.
There is incredible new innovation in genetics and technology, creating new life-saving and life enhancing opportunities. With three, big pharmaceutical companies buying hot biotech companies to keep their pipelines full to avoid revenue shortfalls created by patent expiration.
The best part some of the biggest biotech opportunities can be found in the smallest of stocks. So here are three up and coming biotech penny stocks for 2020.
Top Biotech Penny Stocks for 2020: PharmaCyte Biotech (Stock: PMCB)
Pharmacyte Biotech just partnered with Hai Kang Life Corporation to deliver a testing solution that could offer a much more accurate test than is currently being used globally and the test is reportedly 10 times more sensitive than the other tests being used to detect the virus.
“We will be able to help with the shortage of accurate diagnostic kits. If we obtain approval, it should provide an immediate and material stream of revenue to us to help fund our other endeavors, while at the same time, helping a world in dire need for the product we are trying to get approved for use in the clinic,” noted the company.
Penny Stocks for 2020: Medigus Ltd. (Stock: MDGS)
Medigus Ltd., a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States and internationally.
Just signed a collaboration agreement with L-1 Systems Ltd. for the joint commercialization of various COVID-19 related products and solutions to governmental agencies and institutional healthcare organizations, according to the company. It also just received its first commercial order for 10,000 COVID-19 serological test kits and signed a binding letter of intent with Polyrizon Ltd. for the purpose of protecting patients against biological threats, says Medigus Ltd.
Penny Stocks for 2020: iBio Inc. (Stock: IBIO)
IBIO is deeply involved with COVID-19 and the company just announced the signing of two Master Services Agreements and a Memorandum of Understanding with the Infectious Disease Research Institute in support of iBio’s SARS-CoV-2 Virus-Like Particle vaccine development, says the company.
“If our own proprietary SARS-CoV-2 Virus-Like Particle program, IBIO-200, results in an approved vaccine, we estimate that we could make about 500 million doses of high-quality product annually at our Texas facility, depending upon the potency we see in the clinic,” said Tom Isett , Co-Chairman & CEO.
Pursuant to an agreement between TD Media LLC and Complete Investment Management LLC , TD Media LLC has been hired for a period beginning on 4/27/20 and ending on 5/25/20 to publicly disseminate information about (PMCB) via digital communications. We have been paid fifty thousand USD via bank wire transfer. We own zero shares of (PMCB).